Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 5
2006 1
2012 2
2013 1
2014 1
2015 4
2016 10
2017 14
2018 15
2019 18
2020 14
2021 14
2022 16
2023 14
2024 13
2025 15
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Results by year

Filters applied: . Clear all
Page 2
Update Breast Cancer 2024 Part 2 - Patients with Early Stage Breast Cancer.
Janni W, Kolberg HC, Hartkopf AD, Fehm TN, Welslau M, Müller V, Schütz F, Fasching PA, Jackisch C, Marme F, Hörner M, Keller K, Goossens C, Belleville E, Untch M, Thill M, Tesch H, Ditsch N, Lux MP, Banys-Paluchowski M, Wöckel A, Harbeck N, Stickeler E, Bartsch R, Aktas B, Schneeweiss A, Ettl J, Taran FA, Lüftner D, Würstlein R, Radosa JC. Janni W, et al. Among authors: kolberg hc. Geburtshilfe Frauenheilkd. 2025 May 15;85(5):493-506. doi: 10.1055/a-2533-2783. eCollection 2025 May. Geburtshilfe Frauenheilkd. 2025. PMID: 40386499 Free PMC article.
Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial.
Beierlein M, Häberle L, Nabieva N, Maass N, Aktas B, Kümmel S, Thomssen C, Wolf C, Kolberg HC, Brucker C, Janni W, Dall P, Schneeweiss A, Marme F, Sütterlin MW, Ruebner M, Theuser AK, Hofmann NM, Böhm S, Almstedt K, Kellner S, Gass P, Lück HJ, Hein A, Schmatloch S, Kalder M, Uleer C, Juhasz-Böss I, Hanf V, Jackisch C, Müller V, Rack B, Belleville E, Wallwiener D, Rody A, Rauh C, Bayer CM, Uhrig S, Huebner H, Goossens C, Brucker SY, Hack CC, Fehm TN, Fasching PA. Beierlein M, et al. Among authors: kolberg hc. Int J Cancer. 2025 Dec 1;157(11):2363-2373. doi: 10.1002/ijc.70037. Epub 2025 Jul 11. Int J Cancer. 2025. PMID: 40641449 Free PMC article. Clinical Trial.
Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer.
Michel LL, Ziegler P, Kreis P, Hartkopf AD, Wallwiener M, Häberle L, John N, Kolberg HC, Hadji P, Tesch H, Ettl J, Lüftner D, Müller V, Belleville E, Wimberger P, Enzinger HM, Huebner H, Uhrig S, Hack CC, Krabisch P, Fasching PA, Wuerstlein R, Untch M, Ditsch N, Hein A, Janni W, Taran FA, Lux MP, Wallwiener D, Brucker SY, Fehm TN, Schneeweiss A, Goossens C, Engler T. Michel LL, et al. Among authors: kolberg hc. Eur J Cancer. 2025 Sep 9;227:115689. doi: 10.1016/j.ejca.2025.115689. Epub 2025 Aug 5. Eur J Cancer. 2025. PMID: 40780076 Free article.
Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients - Results from the prospective AXSANA registry trial.
Di Micco R, Hartmann S, Banys-Paluchowski M, de Boniface J, Schmidt E, Ditsch N, Stickeler E, Schroth J, Karadeniz Cakmak G, Hahn M, Thill M, Lux MP, Kolberg HC, Rubio IT, Gasparri ML, Kontos M, Bonci EA, Niinikoski L, Murawa D, Pinto D, Peintinger F, Schlichting E, Nina H, Valiyeva Qanimat H, Vanhoeij M, Rebaza L, Kadayaprath G, Porpiglia M, Gentilini OD, Kühn T; AXSANA Study Group. Di Micco R, et al. Among authors: kolberg hc. Eur J Cancer. 2025 Aug 26;226:115607. doi: 10.1016/j.ejca.2025.115607. Epub 2025 Jul 5. Eur J Cancer. 2025. PMID: 40645031
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study.
Banys-Paluchowski M, Hartmann S, de Boniface J, Gentilini OD, Ditsch N, Stickeler E, Karadeniz Cakmak G, Hauptmann M, Schroth J, Thill M, di Micco R, Hahn M, Murawa D, Rubio IT, Pinto D, Kontos M, Niinikoski L, Gasparri ML, Nina H, Rebaza LP, Fröhlich S, Schmidt E, Wihlfahrt K, Berger T, Basali T, Ruf F, Rief A, Bonci EA, Peintinger F, Schlichting E, Valiyeva Qanimat H, Vanhoeij M, Kadayaprath G, Dostalek L, Kothari A, Perhavec A, Ivanov T, Zippel D, Adamczyk B, Porpiglia M, Gürleyik GM, Untch M, Lux MP, Jursik K, Kolberg HC, Reimer T, Tauber N, Rody A, Matrai Z, Krawczyk N, Thongvitokomarn S, Kühn T. Banys-Paluchowski M, et al. Among authors: kolberg hc. J Clin Oncol. 2026 Mar;44(7):575-585. doi: 10.1200/JCO-25-01921. Epub 2026 Jan 21. J Clin Oncol. 2026. PMID: 41564379
153 results